CBUS Cibus US LLC
Price Chart
Executive Summary
Cibus US LLC (CBUS) announced plans for an underwritten public offering of its Class A common stock and pre-funded warrants, with an option for underwriters to purchase up to an additional 15%. The company intends to use net proceeds for working capital, general corporate purposes, and to fund development of weed management traits in rice. The offering is subject to market conditions and regulatory filings.
Actionable Insight
Monitor the prospectus supplement for final pricing, share count, and dilution impact. Assess whether the capital raise aligns with prior R&D spend and runway needs. Watch for insider participation or secondary components that could signal confidence or selling pressure.
Key Facts
- Cibus announced a proposed public offering of Class A common stock and pre-funded warrants.
- Underwriter granted a 30-day option to purchase up to an additional 15% of shares.
- BTIG, LLC is the sole underwriter.
- Proceeds will be used for working capital, general corporate purposes, and development of weed management traits in rice.
- Offering will be made under an effective shelf registration (Form S-3, File No. 333-273062), with a prospectus supplement to be filed.
Financial Impact
Dilutive offering — size not disclosed; potential for moderate dilution depending on final share count and pricing.
Risk Factors
- Dilution to existing shareholders depending on offering size and price.
- Downward pressure on stock price if offering is priced at a discount or perceived as urgent.
- Use of proceeds lacks specificity — funds are for 'general corporate purposes' which may lack strategic focus.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3262555 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
2d ago
|
Institutional Cluster
| $1.21 awaiting T+5 | awaiting T+5 | — | $1.23 (+2.07%) |
|
Jun 9, 2026
4d ago
|
8-K
| $1.22 awaiting T+5 | awaiting T+5 | — | $1.23 (+1.23%) |
|
Jun 8, 2026
4d ago
|
Press Release
| $1.22 awaiting T+5 | awaiting T+5 | — | $1.23 (+1.23%) |
|
May 26, 2026
18d ago
|
EFFECT
| $1.43 $1.39 | ▲ +2.80% | ▲ +4.01% | $1.23 (+13.99%) |
|
May 14, 2026
29d ago
|
8-K
| $1.31 $1.38 | ▲ +5.34% | ▲ +4.38% | $1.23 (−6.11%) |
|
May 4, 2026
5w ago
|
Press Release
| $1.49 $1.38 | ▼ −7.38% | ▼ −10.32% | $1.23 (−17.45%) |
|
Apr 20, 2026
7w ago
|
DEFA14A
| $1.49 $1.42 | ▼ −4.70% | ▼ −5.78% | $1.23 (−17.45%) |
|
Mar 26, 2026
11w ago
|
424B5
| $1.88 $1.91 | ▼ −1.60% | ▲ +2.27% | $1.23 (+34.57%) |
|
Mar 26, 2026
11w ago
|
Press Release
| $2.13 $1.98 | ▼ −7.04% | ▼ −8.68% | $1.23 (−42.25%) |
|
Mar 25, 2026
11w ago
|
Press Release
| $2.13 $1.98 | ▼ −7.04% | ▼ −8.68% | $1.23 (−42.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access